Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2020

13.08.2020 | Commentary

Marketing of healthcare services in Denmark: the concept of misleading advertising

verfasst von: Lise Aagaard

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

As severe ill and incurable patients can be easy victims of misleading advertising activities for dangerous and non-effective healthcare treatments, the marketing of healthcare services are in many jurisdictions legislations tightly regulated. This article reviews the Danish regulation on marketing of healthcare services to identify which types of advertising activities that are legal. As the legislation only allows healthcare authorities to control the marketing and not the content and quality of the marketed healthcare services, their ability to intervene in serious cases of misleading advertising is limited. Misleading advertising are statements with the purpose to exaggerate or underestimate the effects and risks of healthcare services or to prevent patients from seeking conventional medical treatments. From a public health perspective, there is a need for a common EU legislation for regulation of the marketing of healthcare services as the increasing use of information technologies makes it possible for the providers to access consumers and patients directly across countries and legal systems.
Literatur
1.
Zurück zum Zitat Carrasquillo O. Health care utilization. In: Gellman MD, Turner JR, editors. Encyclopedia of behavioral medicine. New York: Springer; 2013. Carrasquillo O. Health care utilization. In: Gellman MD, Turner JR, editors. Encyclopedia of behavioral medicine. New York: Springer; 2013.
2.
Zurück zum Zitat Schenker Y, Arnold RM, London AJ. The ethics of advertising for health care services. Am J Bioeth. 2014;14(3):34–43.CrossRef Schenker Y, Arnold RM, London AJ. The ethics of advertising for health care services. Am J Bioeth. 2014;14(3):34–43.CrossRef
11.
Zurück zum Zitat Aagaard L, Kristensen K. Off-label and Unlicensed Prescribing in Europe: Implications for Patients’ Informed Consent and Liability. Int J Clin Pharm. 2018;40:509–12.CrossRef Aagaard L, Kristensen K. Off-label and Unlicensed Prescribing in Europe: Implications for Patients’ Informed Consent and Liability. Int J Clin Pharm. 2018;40:509–12.CrossRef
Metadaten
Titel
Marketing of healthcare services in Denmark: the concept of misleading advertising
verfasst von
Lise Aagaard
Publikationsdatum
13.08.2020
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2020
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01111-3

Weitere Artikel der Ausgabe 6/2020

International Journal of Clinical Pharmacy 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.